North America Cancer Diagnostics Market Size Set Expands at Significant CAGR of 6.11% During 2024–2030 to Reach USD 23.48 Billion by 2030
North America cancer diagnostics market is flourishing due to the growing aging population, proactive government initiatives for cancer screening programs, and continuous research and development efforts in the healthcare sector. Innovative diagnostic tools and personalized medicine approaches are further contributing to the North America cancer diagnostics market growth.

